Dan Troy on the FDA, Free Speech, and the Future of Drug Innovation Titelbild

Dan Troy on the FDA, Free Speech, and the Future of Drug Innovation

Dan Troy on the FDA, Free Speech, and the Future of Drug Innovation

Jetzt kostenlos hören, ohne Abo

Details anzeigen
ZEITLICH BEGRENZTES ANGEBOT. Nur 0,99 € pro Monat für die ersten 3 Monate. 3 Monate für 0,99 €/Monat, danach 9,95 €/Monat. Bedingungen gelten. Jetzt starten.

Über diesen Titel

 In this episode of DC EKG, host Joe Grogan sits down with Dan Troy, former Chief Counsel of the FDA and a nationally recognized expert on healthcare law and the First Amendment. They explore Troy’s unique journey from free speech litigator to one of the FDA’s top legal voices, examining how the agency regulates what drugmakers, doctors, and companies are allowed to say—and what they’re not. The conversation dives into the legal boundaries of off-label promotion, the impact of direct-to-consumer advertising on patient care, and the growing tension between innovation and regulation in the pharmaceutical industry. Troy also offers his perspective on the Inflation Reduction Act and its potential chilling effect on drug development, underscoring the need for bipartisan support in shaping healthcare policy.
Noch keine Rezensionen vorhanden